- DESCRIPTION
- TABLE OF CONTENTS
- METHODOLOGY
- DOWNLOAD PDF
Vendor Neutral Archive (VNA) & PACS Market by Product Type (Department, Multi-department, Multi-site), Modality (CT, MRI, X-ray, Ultrasound, Mammo), Application (Cardio, Onco, Neuro), End User (Hospital, ASC, Diagnostic Center) - Global Forecast to 2031
USD 8.57 BN
MARKET SIZE, 2031
CAGR 8.9%
(2026-2031)
289
REPORT PAGES
316
MARKET TABLES
OVERVIEW

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global vendor-neutral archive (VNA) & picture archiving and communication systems (PACS) market is projected to grow to USD 8.57 billion by 2031 from USD 5.60 billion in 2026, growing at a CAGR of 8.9%. This growth is driven by the rapid digital transformation of healthcare infrastructure and increasing adoption of cloud-based archiving and AI-enhanced diagnostic tools that support remote workflows and data-driven care.
KEY TAKEAWAYS
-
By Region
North America accounted for the largest share (42.9%) of the VNA & PACS market in 2025.
-
By Modality
By modality, the X-ray segment accounted for the largest share (42.8%) of the VNA & PACS market in 2025.
-
By Deployment Model
The cloud-based deployment models segment is projected to register the highest CAGR (10.4%) from 2026 to 2031.
-
By Product Type
The VNA segment accounted for the largest market share in 2025.
-
By Vendor Type
The independent vendors segment accounted for the largest share in 2025
-
By Application
The cardiology segment accounted for the largest share in 2025.
-
By End User
The hospital & clinics segment is projected to have the highest CAGR during the study period.
The growth in the medical imaging sector is predominantly fueled by the escalating volume of imaging data and a stronger regulatory push for EHR implementation. Additionally, the ongoing transition towards value-based care is prompting increased investments in scalable and interoperable imaging solutions. Key technological advancements, such as cloud-based storage, Al, and analytics integration, are significantly driving the adoption of VNA and PACS; these innovations facilitate improved clinical workflows, enhance data accessibility, and ultimately lead to better patient care outcomes.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The VNA & PACS market is being significantly disrupted by the convergence of cloud technologies, AI-enabled imaging workflows, and enterprise-wide data interoperability. Traditional siloed PACS are rapidly being replaced by cloud-native VNAs that support both DICOM and non-DICOM formats, enabling unified access across departments and care settings. The growing demand for remote diagnostics, teleradiology, and mobile access is accelerating the need for zero-footprint universal viewers, while rising cybersecurity threats are driving adoption of more secure, scalable, and compliant storage architectures.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
-
Heightened investments in medical imaging technologies

-
Growing demand for streamlined healthcare data management solutions
RESTRAINTS
Impact
Level
-
High initial investment for implementing VNA and PACS solutions
-
Lack of standardized protocols and interoperability frameworks
OPPORTUNITIES
Impact
Level
-
Favorable government initiatives for better penetration of AI in medical imaging
-
Increasing medical imaging procedures and large imaging data silos
CHALLENGES
Impact
Level
-
Rising security concerns related to cloud-based image processing and analytics
-
Data security issues in healthcare settings
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Medical imaging employs various techniques, such as X-ray, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI), to diagnose illnesses and provide insights into internal bodily conditions. Factors propelling investments in medical imaging technologies include governmental initiatives to modernize imaging facilities and research, the proliferation of diagnostic imaging centers, technological advancements in diagnostic imaging techniques, and patients’ growing preference for minimally invasive treatments
The significant initial investment required for implementing VNA and PACS solutions poses a notable restraint on the market. Healthcare facilities considering the adoption of VNA and PACS technologies often face substantial upfront costs associated with infrastructure, software licenses, and training. These costs can present a considerable barrier to entry, particularly for smaller healthcare providers or facilities operating on a limited budget.
Innovative solutions, such as AI-based solutions, are used to interpret the massive volume of medical imaging and diagnosis data and transfer it into actionable, useful information that physicians, radiologists, and researchers can use to improve the quality of care. Realizing the benefits of AI-based solutions, government organizations in various countries are increasingly undertaking initiatives to increase the adoption of AI-based technologies in their respective healthcare systems
In spite of the benefits offered by cloud computing, it is associated with several concerns related to integrity, availability, privacy, and confidentiality. Owing to the large number of issues related to cloud data storage, such as data breaches, data theft, and unavailability of cloud data, cloud service providers (CSPs) are required to ensure reliable data services to customers and their stored data. Although cloud computing has certain benefits, many users are still unwilling to store their confidential data in cloud data centers, such as personal health records, diagnostic imaging data, and government-sensitive files. Clients lose direct control over their data sources once the data is stored in a data center. CSPs are continuously striving to ensure data security by using mechanisms such as firewalls and virtualization. These mechanisms, however, cannot entirely provide complete data protection owing to network vulnerabilities and control issues CSPs face regarding cloud applications, hardware, and client data
VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Offers enterprise imaging solutions with embedded VNA and PACS for multi-department use. | Enhances interoperability and reduces data silos across radiology and cardiology systems. |
|
|
Provides Synapse VNA for centralized archiving of imaging data from disparate systems. | Improves data accessibility and long-term storage efficiency, supporting clinical decisions. |
|
|
Delivers enterprise imaging PACS integrated with VNA for hospitals and imaging centers. | Facilitates faster diagnosis and collaboration with unified access to image data. |
|
|
Supplies scalable PACS and cloud-enabled VNAs for large healthcare networks. | Lowers IT overhead while enabling secure, remote access to imaging records. |
|
|
Offers cloud-based VNA solutions with AI-driven image management. | Streamlines workflow and enhances diagnostic accuracy with intelligent data organization. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The VNA & PACS market ecosystem comprises a network of healthcare providers, imaging vendors, cloud service providers, and interoperability standards bodies working together to enable seamless storage, access, and exchange of medical images. Core participants include PACS/VNA software vendors, modality manufacturers (MRI, CT, etc.), cloud infrastructure providers, and cybersecurity firms. Supporting stakeholders like AI-powered imaging analytics companies, teleradiology platforms, and healthcare system integrators further enhances clinical workflows. This interconnected ecosystem is driven by a shared goal of achieving enterprise imaging, cross-vendor compatibility, and improved patient care across regions and healthcare settings.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
In 2025, the VNA segment held the largest share of the VNA & PACS market due to its capability to provide a centralized repository for storing medical images and related metadata in a standardized format, independent of specific imaging modalities or vendors. VNA enables efficient interoperability for data exchange across diverse systems and healthcare facilities, thereby enhancing collaboration and care coordination among providers. The VNA landscape can be delineated into three categories: departmental, multi-department, and multi-site VNA, each tailored to address the specific requirements of various levels within healthcare organizations. These solutions are essential for handling substantial volumes of imaging data, ensuring that medical images are readily accessible across multiple departments, locations, and systems; this access not only streamlines operational workflows but also optimizes patient care delivery. As the healthcare sector increasingly adopts value-based care models, the significance of comprehensive data management solutions, such as VNA, has escalated. Furthermore, VNA empowers healthcare organizations to leverage medical imaging data for initiatives related to population health management, predictive analytics, and personalized medicine. This strategic positioning has established VNA solutions as pivotal contributors to the evolving landscape of medical imaging and healthcare informatics.
The VNA & PACS market is segmented by deployment into cloud-based, on-premises, and hybrid deployment. The cloud-based segment is poised for robust growth throughout the forecast period, driven by a multitude of advantageous factors. Cloud-based VNA and PACS solutions eliminate the necessity for substantial investments in on- premises infrastructure, allowing healthcare organizations to leverage scalable storage and computing resources that can be dynamically configured according to fluctuating demand. This adaptability is particularly critical as healthcare entities grapple with the surging volumes of medical imaging data generated from diagnostic modalities such as X-rays, MRIs, and CT scans. Cloud service providers (CSPs) employ comprehensive security measures-including encryption, stringent access controls, and periodic security audits-to ensure the integrity and confidentiality of patient data. These protocols are essential for meeting regulatory compliance standards such as HIPAA and GDPR, mitigating the risks associated with potential data breaches, which are a major concern for healthcare organizations managing sensitive medical information. In addition, the cost-efficiency of cloud deployment models presents a compelling incentive for organizations aiming to curtail capital expenditures on physical infrastructure while capitalizing on the inherent flexibility of cloud storage solutions. The benefits of remote access and real-time monitoring afforded by cloud-based systems facilitate enhanced collaboration among healthcare professionals, enabling seamless access to imaging data across geographically dispersed locations while ensuring the health and security of the data remain intact.
Based on modality, the VNA & PACS market is segmented into CT, mammography, MRI, ultrasound, X-rays, and PET. The CT segment held the largest market in 2025 due to the growing need for accurate and early diagnosis, advancements in technology, and the digitalization of healthcare. Additionally, CT scans play a crucial role in preventing unnecessary surgeries, improving cancer diagnosis and treatment, and enhancing patient care. Thus, the efficiency, versatility, and effectiveness of CT scans have made them indispensable in modern healthcare, driving their dominance in the VNA & PACS market as the preferred imaging modality for a diverse range of medical applications
Based on end-user, the VNA & PACS market is segmented into hospitals & clinics, diagnostic centers, ambulatory surgical centers, and other end users, including research and academic institutes. The hospitals & clinics segment dominates the end-user segment of the VNA & PACS market, as these healthcare facilities generate vast volumes of medical imaging data daily, necessitating robust solutions for managing, storing, and efficiently accessing this data. Moreover, these solutions provide a centralized repository for storing medical images and associated metadata in a standardized format, enabling seamless access and retrieval of patient information across different departments and facilities within hospitals and clinics. Owing to the increasing demand for personalized, data-driven care, the hospitals and clinics segment will remain at the forefront of innovation and investment in VNA and PACS solutions to meet the evolving needs of patients and healthcare professionals alike.
Based on vendor type, the VNA & PACS market is segmented into independent vendors and third-party vendors. Third-party vendors are expected to be the fastest-growing during the forecast period due to their ability to provide flexible, interoperable solutions that integrate across multi-vendor imaging environments. Their offerings often include cost-effective cloud-based storage, enhanced data migration services, and scalable solutions that reduce IT complexity. Additionally, the increasing demand for cross-enterprise data sharing and the shift toward subscription-based models further fuel the growth of third-party VNA & PACS vendors.
Based on application, the VNA & PACS market is segmented into cardiology, orthopedic, oncology, neurology, obstetrics & gynecology, and other applications. The cardiology segment held the largest market share in 2025 due to the high volume of imaging procedures, such as echocardiograms, CT, and MRI scans, which require efficient storage and retrieval systems. The rising prevalence of cardiovascular diseases, growing adoption of advanced imaging technologies for early diagnosis, and increasing integration of AI-driven analytics in cardiac imaging are key drivers supporting the segment's dominance. Moreover, the demand for seamless cross-departmental access to imaging data to support timely interventions in critical care further propels market growth.
REGION
APAC is estimated to register the highest CAGR during the forecast period
The VNA & PACS market in APAC is projected to register the highest CAGR during the forecast period. The growth of this region is due to rising medical imaging investments and technological advancements in diagnostic imaging modalities. Moreover, advancements in technology and the growing prevalence of cloud computing are making VNA and PACS more accessible and affordable in APAC. As healthcare providers in this region continue to prioritize efficiency, accessibility, and quality of care, VNA and PACS solutions will play a pivotal role in driving healthcare transformation and improving patient outcomes across the region.

VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMPANY EVALUATION MATRIX
In the VNA & PACS market matrix, Agfa Healthcare (Star) leads with a strong market presence and comprehensive imaging portfolio, offering interoperable VNA and PACS solutions that support multi-department enterprise imaging across global healthcare networks. Intelerad (Emerging Leader) is rapidly gaining traction with its cloud-native PACS and enterprise imaging platforms, delivering scalable and flexible solutions that appeal to mid-sized and large imaging providers. While Agfa dominates through a broad installed base and end-to-end imaging workflows, Intelerad shows strong momentum to advance toward the leaders' quadrant as cloud adoption and demand for integrated, AI-ready platforms continue to rise.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Agfa-Gevaert Group. (Belgium)
- FUJIFILM Holdings Corporation (Japan)
- GE Healthcare (US)
- Merative (US)
- Sectra AB (Sweden)
- Koninklijke Philips N.V. (Netherland)
- Hyland Software, Inc. (US)
- CANON MEDICAL SYSTEMS CORPORATION (Japan)
- Siemens Healthineers AG (Germany)
- BridgeHead Software Ltd. (UK)
- Canopy Partners. (US)
- Novarad Corporation. (US)
- POSTDICOM (Netherlands)
- AdvaHealth Solutions Pte Ltd (Singapore)
- CrelioHealth (India)
- Esaote SPA (Italy)
- PaxeraHealth (US)
- VISUS Health IT GmbH (Germany)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) (Base Year) | USD 5.10 BN |
| Market Size in 2026 (Value) (Estimated Year) | USD 5.60 Billion |
| Market Forecast in 2031 (Value) (Forecast Year) | USD 8.57 Billion |
| CAGR | 8.9% |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | USD Billion |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Asia Pacific, Europe, the Middle East & Africa, Latin America |
WHAT IS IN IT FOR YOU: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: GROWTH, SIZE, SHARE, AND TRENDS REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Pricing and distribution channel of VNA & PACS market | Delivered detailed analysis of pricing models (subscription, perpetual license, tiered storage) and distribution channels (direct sales, system integrators, cloud marketplaces, and OEM partnerships) | Enabled the client to refine their go-to-market strategy and align pricing to competitive and buyer expectations |
RECENT DEVELOPMENTS
- April 2025 : Siemens Healthineers (Germany) and Tower Health (US) unveiled a 10-year value partnership to upgrade imaging systems and digital tools and enhance diagnostic capabilities.
- March 2025 : GE Healthcare (US) launched the Genesis Cloud Suite, an enterprise imaging SaaS portfolio offering edge, storage, VNA, and data migration solutions to improve workflow efficiency, precision, and IT resource optimization for healthcare providers.
- March 2025 : FUJIFILM Healthcare Americas (US) partnered with AWS (US) to enhance digital pathology and cloud integration to streamline data lifecycle management and optimize storage of large pathology files within Fujifilm's Synapse Pathology platform.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
15
2
EXECUTIVE SUMMARY
3
PREMIUM INSIGHTS
4
MARKET OVERVIEW
4.1
INTRODUCTION
4.2
MARKET DYNAMICS
4.2.1
DRIVERS
4.2.2
RESTRAINTS
4.2.3
OPPORTUNITIES
4.2.4
CHALLENGES
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMICS INDICATORS
5.2.1
INTRODUCTION
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.3
VALUE CHAIN ANALYSIS
5.4
ECOSYSTEM ANALYSIS
5.5
PRICING ANALYSIS
5.5.1
INDICATIVE PRICING FOR VNA & PACS MARKET, BY PRODUCT TYPE (2025)
5.5.2
INDICATIVE PRICING FOR VNA & PACS MARKET, BY REGION (2025)
5.6
KEY CONFERENCES AND EVENTS, 2026–2028
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.8
INVESTMENT AND FUNDING SCENARIO
5.9
CASE STUDY ANALYSIS
5.10
IMPACT OF 2026 US TARIFF – VNA & PACS MARKET
5.10.1
INTRODUCTION
5.10.2
KEY TARIFF RATES
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON COUNTRIES/REGIONS
5.10.4.1
US
5.10.4.2
EUROPE
5.10.4.3
APAC
5.10.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE (DICOM)
6.1.2
ENTERPRISE IMAGING SOLUTIONS
6.1.3
CLOUD-BASED STORAGE AND SERVICES
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
IMAGE EXCHANGE NETWORKS.
6.2.2
DATA ANALYTICS AND BUSINESS INTELLIGENCE
6.3
ADJACENT TECHNOLOGIES
6.3.1
HEALTH INFORMATION EXCHANGE (HIE)
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.5
PATENT ANALYSIS
6.6
FUTURE APPLICATIONS
7
REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2
INDUSTRY STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5
MARKET PROFITABILITY
9
VNA & PACS MARKET, BY PRODUCT TYPE (MARKET SIZE & FORECAST TO 2031)
9.1
INTRODUCTION
9.2
VNA
9.2.1
DEPARTMENT VNA
9.2.2
MULTI-DEPARTMENT VNA
9.2.3
MULTI-SITE VNA
9.3
PACS
9.3.1
DEPARTMENT PACS
9.3.2
MULTI-DEPARTMENT PACS
9.3.3
MULTI-SITE PACS
10
VNA & PACS MARKET, BY MODALITY (MARKET SIZE & FORECAST TO 2031)
10.1
INTRODUCTION
10.2
CT
10.3
MAMMOGRAPHY
10.4
MRI
10.5
ULTRASOUND
10.6
X-RAYS
10.7
PET
11
VNA & PACS MARKET, BY DEPLOYMENT (MARKET SIZE & FORECAST TO 2031)
11.1
INTRODUCTION
11.2
ON-PREMISE DEPLOYMENT
11.3
CLOUD-BASED DEPLOYMENT
11.4
HYBRID DEPLOYMENT
12
VNA & PACS MARKET, BY VENDOR TYPE (MARKET SIZE & FORECAST TO 2031)
12.1
INTRODUCTION
12.2
INDEPENDENT VENDOR
12.3
THIRD-PARTY VENDOR
13
VNA & PACS MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2031)
13.1
INTRODUCTION
13.2
CARDIOLOGY
13.3
ORTHOPEDIC
13.4
ONCOLOGY
13.5
NEUROLOGY
13.6
OBSTETRICS AND GYNECOLOGY
13.7
OTHER APPLICATIONS
14
VNA & PACS MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031)
14.1
INTRODUCTION
14.2
HOSPITALS & CLINICS
14.3
DIAGNOSTICS CENTERS
14.4
AMBULATORY SURGICAL CENTERS
14.5
OTHER END USERS
15
VNA & PACS MARKET, BY REGION (MARKET SIZE & FORECAST TO 2031)
15.1
INTRODUCTION
15.2
NORTH AMERICA
15.2.1
US
15.2.2
CANADA
15.3
EUROPE
15.3.1
GERMANY
15.3.2
FRANCE
15.3.3
UK
15.3.4
ITALY
15.3.5
SPAIN
15.3.6
REST OF EUROPE
15.4
ASIA PACIFIC
15.4.1
CHINA
15.4.2
JAPAN
15.4.3
INDIA
15.4.4
AUSTRALIA
15.4.5
SOUTH KOREA
15.4.6
REST OF ASIA PACIFIC
15.5
LATIN AMERICA
15.5.1
BRAZIL
15.5.2
MEXICO
15.5.3
REST OF LATIN AMERICA
15.6
MIDDLE EAST & AFRICA
15.6.1
GCC COUNTRIES
15.6.1.1
SAUDI ARABIA
15.6.1.2
UAE
15.6.1.3
REST OF GCC
15.6.2
SOUTH AFRICA
15.6.3
REST OF MIDDLE EAST & AFRICA
16
COMPETITIVE LANDSCAPE
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
16.1
OVERVIEW
16.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
16.3
REVENUE ANALYSIS (2021-2025)
16.4
MARKET SHARE ANALYSIS (2025)
16.5
BRAND/SOFTWARE COMPARATIVE ANALYSIS
16.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
16.6.1
STARS
16.6.2
EMERGING LEADERS
16.6.3
PERVASIVE PLAYERS
16.6.4
PARTICIPANTS
16.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
16.6.5.1
COMPANY FOOTPRINT
16.6.5.2
REGION FOOTPRINT
16.6.5.3
PRODUCT TYPE FOOTPRINT
16.6.5.4
DEPLOYMENT FOOTPRINT
16.6.5.5
END USER FOOTPRINT
16.7
COMPANY EVAULATION MATRIX: STARTUPS/SMES,
16.7.1
PROGRESSIVE COMPANIES
16.7.2
DYNAMIC COMPANIES
16.7.3
RESPONSIVE COMPANIES
16.7.4
STARTING BLOCKS
16.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
16.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
16.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
16.8
COMPANY VALUATION AND FINANCIAL METRICS
16.9
COMPETITIVE SCENARIOS
16.9.1
PRODUCT LAUNCHES & UPGRADES
16.9.2
DEALS
16.9.3
EXPANSIONS
16.9.4
OTHERS
17
COMPANY PROFILES
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, SERVICES, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE VNA & PACS MARKET LANDSCAPE
17.1
KEY PLAYERS
17.1.1
KONINKLIJKE PHILIPS N.V.
17.1.2
SIEMENS HEALTHINEERS AG
17.1.3
GE HEALTHCARE
17.1.4
FUJIFILM HOLDINGS CORPORATION
17.1.5
CANON MEDICAL SYSTEMS CORPORATION
17.1.6
AGFA-GEVAERT GROUP
17.1.7
MERATIVE
17.1.8
HYLAND SOFTWARE, INC.
17.1.9
SECTRA AB
17.1.10
ESAOTE SPA
17.1.11
VISUS HEALTH IT GMBH
17.1.12
PAXERAHEALTH
17.1.13
NOVARAD CORPORATION
17.1.14
BRIDGEHEAD SOFTWARE LTD.
17.1.15
CANOPY PARTNERS
17.1.16
ASPYRA, LLC
17.1.17
POSTDICOM
17.1.18
CRELIOHEALTH
17.1.19
MEDICASOFT
17.2
OTHER PLAYERS
17.2.1
ADVAHEALTH SOLUTIONS.
17.2.2
SOFTTEAM SOLUTIONS PVT LTD.
17.2.3
ARO SYSTEMS
17.2.4
CENTRAL DATA NETWORKS
17.2.5
ONEPACS
17.2.6
DEDALUS S.P.A
18
RESEARCH METHODOLOGY
18.1
RESEARCH DATA
18.1.1
SECONDARY DATA
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
18.1.2
PRIMARY DATA
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
18.1.2.2
KEY PRIMARY PARTICIPANTS
18.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
18.1.2.4
KEY INDUSTRY INSIGHTS
18.2
MARKET SIZE ESTIMATION
18.2.1
BOTTOM-UP APPROACH
18.2.2
TOP-DOWN APPROACH
18.2.3
BASE NUMBER CALCULATION
18.3
MARKET FORECAST APPROACH
18.3.1
SUPPLY SIDE
18.3.2
DEMAND SIDE
18.4
DATA TRIANGULATION
18.5
FACTOR ANALYSIS
18.6
RESEARCH ASSUMPTIONS
18.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
19
APPENDIX
19.1
DISCUSSION GUIDE
19.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
19.3
CUSTOMIZATION OPTIONS
19.4
RELATED REPORTS
19.5
AUTHOR DETAILS
Methodology
The study involved five major activities to estimate the current size of the VNA & PACS market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for the study of the VNA PACS market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the VNA & PACS market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
BREAKDOWN OF PRIMARIES

Note 2: Tiers of companies are defined based on their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the VNA & PACS market. These methods were also used extensively to estimate the size of various subsegments in the market.

Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and determine the exact statistics for each market segment and sub-segment, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the VNA & PACS market.
Market Definition
VNA and PACS are medical imaging technologies that offer cost-effective storage and easy access to images from various modalities. These solutions are essential elements of modern healthcare IT infrastructure, enabling the efficient and secure digitization, storage, retrieval, and sharing of medical imaging data.
Key Stakeholders
- VNA & PACS vendors
- Government bodies
- Healthcare service providers
- Clinical/Physician centers
- Healthcare professionals
- Health IT service providers
- Healthcare associations/institutes
- Ambulatory care centers
- Venture capitalists
- Distributors and resellers
- Maintenance and support service providers
- Integration service providers
- Healthcare players
Report Objectives
- To define, describe, and forecast the VNA & PACS market based on product type, modality, deployment, vendor type, application, end user, and region
- To provide detailed information regarding the factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets¹ with respect to individual growth trends, prospects, and contributions to the market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies²
- To track and analyze competitive developments such as product launches and approvals; joint ventures, partnerships, & collaborations; acquisitions; and contracts in the VNA & PACS market.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
- Geographic Analysis: Further breakdown of Latin America, Europe, and the Middle East & Africa VNA & PACS into specific countries
⚡ Growth Signals
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Vendor Neutral Archive (VNA) & PACS Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners

JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Company

We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.

BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Company

We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.

Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnostics
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.

Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money

Still Researching the
Vendor Neutral Archive (VNA) & PACS Ecosystem?
See the competitors, opportunities, and growth signals shaping it - instantly.
Generate 15+ consulting-grade strategic insights tailored to your growth question.



















